Abiopharma

IDEXX Announces CEO Succession

(10% Negative) Rewalk Robotics Ltd (LFWD) Announces Clinical Trial Timeline Adjustment

(75% Positive) Charles River Laboratories International Inc. (CRL) Reports Q1 2026 Financial Results

EPAM Systems, Inc. - EPAM to Host Investor Day on March 12, 2026

Ginkgo Bioworks - Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

Edgewise Therapeutics - Edgewise Therapeutics Provides Corporate Updates and Highlights Priorities for 2026

Omnicell - Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

Johnson & Johnson - Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting

Natera - Natera Announces Next Breakthrough in MRD-Based Risk Stratification, Leveraging Multi-Modal AI Modeling

Alto Neuroscience, Inc. - Alto Neuroscience Presents New Data at the 64th Annual Meeting of the American College of Neuropsychopharmacology

Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

New Form SCHEDULE 13G - KALA BIO, Inc. Filed: 2026-01-13 AccNo: 0001213900-26-003682 Size: 13 KB

(99% Neutral) Acadia Healthcare Company Inc (ACHC) Reports Q1 2026 Financial Results

CytoMed Therapeutics’ new year update and seeks shareholders’ feedback on proposal to improve shareholder value for their patient capital

Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting